Skip to content
You are now leaving https://www.ionispharma.com to visit

Ionis Announces Plans for Management Transitions in 2020

CARLSBAD, Calif. , Dec. 20, 2018 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) and its Board of Directors announced today that, effective January 2020 , Ionis’ founder and CEO, Stanley T. Crooke , M.D., Ph.D., will be transitioning from chief executive officer to executive chairman of